Zakłady Chemiczno-Farmaceutyczne Vissp. z o.o.
Manufacture of pharmaceutical preparations
Overview
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Sprawozdanie zostało sporządzone przy założeniu kontynuacji działalności gospodarczej w dającej się przewidzieć przyszłości. Na chwile obecna nie występują ryzyka które wskazywałyby na brak jej kontynuacji w dającej przewidzieć się przyszłości
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | No decision | |
| Capital expenditure | $9,406 | |
| Grants | $10,919 | |
| Management board pay | $41,436 | |
| Related parties | 8 items |
Filing timeliness
Financial statements were filed on time, on average 115 days early.
- 202501/04/2026
- 202428/02/2025
- 202308/03/2024
- 202205/04/2023
- 202106/04/2022
- 202022/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Zakłady Chemiczno-Farmaceutyczne Vis currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 1998.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Mark without a word element(figurative) | Z.533497 | 5 | Refused | – | |
| DOLODEVIT(word) | Z.183660 | 0, 5 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| Mark without a word element(figurative) | – | |
| DOLODEVIT(word) | – |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to submit declarations of will on behalf of the company independently; however, incurring obligations or disposing of rights with a value exceeding PLN 300,000.00 gross requires the consent of the partners’ meeting.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,096 | $159,870.34 | 99.6364% | |
Others | 4 | $583.47 | 0.3636% |
The articles of association restrict share transfers (type of consent unspecified).
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-07-01.
06 1020 4900 0000 8502 3774 6137- 11 1020 5226 0000 6102 0666 6350
- 60 1020 5226 0000 6602 0673 8555
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $4,698$4,698 |
Buildings and premises | $448.7K$448,680 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 24, 2010 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| Stem Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-29 | PKD change (Removed: 47.91.Z, 96.09.Z; Added: 10.89.A, 96.99.Z) | |
| 2011-06-27 | Address change (Krawiecka 3, 41-902, Bytom → Św. Elżbiety 6 A, 41-905, Bytom) | |
| 2011-01-17 | Share capital reduction (2,137,875.40 PLN → 594,000.00 PLN) | |
| 2006-10-17 | Share capital increase (2,135,500.00 PLN → 2,137,875.40 PLN) | |
| 2006-01-11 | Address change (Bytomska 32, 40-149, Katowice → Krawiecka 3, 41-902, Bytom) |
FAQ
Last updated: 2026-09-29